Patent · US Active

Methods for preventing or treating cardiovascular conditions using il-22 fc fusion proteins

US11136365B2 · kind B2 · utility

0Cited by

54References

28Claims

0Family size

Assignee

Genentech, Inc. · US

Inventors

Justin Scheer · San Francisco, US
Wenjun Ouyang · Foster City, US
Richard Vandlen · Hillsborough, US
Philip E. Hass · Moss Beach, US
Eric Gary Stefanich · Emerald Hills, US
Ganesh A. Kolumam · Foster City, US
Xiaoting Wang · Berkeley, US
Jed ROSS · South San Francisco, US
Nicholas Van Bruggen · Redwood City, US

Key dates

Filing date	Nov 20, 2018
Grant date	Oct 5, 2021
Priority date	—
Expiry date	Apr 18, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to IL-22 polypeptides, IL-22 Fc fusion proteins and IL-22 agonists, composition comprising the same, methods of making and methods of using the composition for the treatment of diseases. The invention also relates to IL-22 receptor associated reagents and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.